Lansoprazole

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

1999 • 3,031 citations

Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report

1997 • 992 citations

An evidence-based appraisal of reflux disease management --- the Genval Workshop Report

1999 • 907 citations

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.

1997 • 767 citations

Updated Guidelines for The Diagnosis and Treatment of Gastroesophageal Reflux Disease

1999 • 544 citations

Food and Drug Administration

2011 • 459 citations

Guidelines for the management of Helicobacter pylori infection

1998 • 417 citations

Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors

2000 • 323 citations

Helicobacter pylori Infection in Children: Recommendations for Diagnosis and Treatment

2000 • 296 citations

A guideline for the treatment and prevention of NSAID-induced ulcers

1998 • 284 citations

The proton-pump inhibitors: Similarities and differences

2000 • 246 citations

A guideline for the treatment and prevention of nsaid-induced ulcers

1998 • 246 citations

Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial

2001 • 236 citations

Omeprazole for treatment of chronic erosive esophagitis in children: A multicenter study of efficacy, safety, tolerability and dose requirements

2000 • 209 citations

Proton Pump Inhibitors and Acid‐Related Diseases

1997 • 202 citations

One week triple therapy for Helicobacter pylori: a multicentre comparative study

1997 • 191 citations

Lansoprazole

1992 • 158 citations

Lansoprazole

1994 • 156 citations

Evaluation of Omeprazole, Lansoprazole, Pantoprazole, and Rabeprazole in the Treatment of Acid-Related Diseases

2000 • 150 citations

Superiority of Lansoprazole vs Ranitidine in Healing Nonsteroidal Anti-inflammatory Drug–Associated Gastric Ulcers

2000 • 150 citations

Expression of an extracellular calcium-sensing receptor in rat stomach

1999 • 124 citations

Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro‐oesophageal reflux disease (GERD) who are resistant to conventional‐dose lansoprazole therapy—a prospective, randomized, multi‐centre study

2000 • 118 citations

Omeprazole and Other Proton Pump Inhibitors: Pharmacology, Efficacy, and Safety, with Special Reference to Use in Children

1998 • 98 citations

Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid‐related dyspepsia in general practice

1997 • 97 citations

The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies

2000 • 96 citations

Withdrawal of Troglitazone and Cisapride

2000 • 96 citations

INDOMETHACIN DAMAGE TO RAT GASTRIC MUCOSA IS MARKEDLY DEPENDENT ON LUMINAL pH

1996 • 95 citations

Lansoprazole

1997 • 92 citations

Infant Pneumococcal Vaccine

2000 • 85 citations

Triple Versus Dual Therapy for Eradicating Helicobacter pylori and Preventing Ulcer Recurrence: A Randomized, Double-Blind, Multicenter Study of Lansoprazole, Clarithromycin, and/or Amoxicillin in Different Dosing Regimens

1998 • 84 citations

Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis

1999 • 84 citations

Growth Inhibitory and Bactericidal Activities of Lansoprazole Compared with Those of Omeprazole and Pantoprazole against Helicobacter pylori

1998 • 73 citations

The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion

1997 • 72 citations

Review article: nonsteroidal anti‐inflammatory drug‐associated gastrointestinal complications—guidelines for prevention and treatment

1999 • 70 citations

Lansoprazole in the treatment of gastrooesophageal reflux disease in childhood

2000 • 62 citations

Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.

2000 • 61 citations

Long-term management of gastroesophageal reflux disease and its complications.

1997 • 60 citations

A Comparison of Rabeprazole, Lansoprazole, and Ranitidine for Improving Preoperative Gastric Fluid Property in Adults Undergoing Elective Surgery

2000 • 57 citations

A Placebo-Controlled Dose-Ranging Study of Lansoprazole in the Management of Reflux Esophagitis

1998 • 55 citations

A Prospective Trial of Lansoprazole Triple Therapy for Pediatric Helicobacter pylori Infection

2000 • 54 citations

Comparison of omeprazole and lansoprazole in short‐term triple therapy for Helicobacter pylori infection

1998 • 49 citations

Safety Profile of Lansoprazole

1999 • 48 citations

Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline

1999 • 44 citations

Efficacy of 7 day lansoprazole‐based triple therapy for Helicobacter pylori infection in elderly patients

1999 • 42 citations

Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole

1997 • 42 citations

Safety and Efficacy of One‐Week Triple Therapy for Eradicating Helicobacter pylori in Children

1998 • 42 citations

Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells.

1999 • 39 citations

Lansoprazole and omeprazole in the prevention of relapse of reflux oesophagitis: a long‐term comparative study

1998 • 39 citations

Management of Severe Gastroesophageal Reflux Disease

2001 • 39 citations

Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury.

1999 • 38 citations

Standard‐dose lansoprazole is more effective than high‐dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis

1999 • 38 citations

Effects of Long-term Treatment with Proton Pump Inhibitors in Gastro-oesophageal Reflux Disease on the Histological Findings in the Lower Oesophagus

2000 • 37 citations

Treatment of Helicobacter pylori

2001 • 36 citations

Gastroduodenal ulcers: Causes, diagnosis, prevention and treatment

1999 • 35 citations

Treatment with lansoprazole also induces hypertrophy of the parietal cells of the stomach

2000 • 35 citations

Pharmacokinetic interaction between proton pump inhibitors and roxithromycin in volunteers

2000 • 33 citations

Proton-pump inhibitors in acid-related diseases

1998 • 33 citations

UK licence for cisapride suspended

2000 • 32 citations

Comparison of the Effect of Lansoprazole and Omeprazole on Intragastric Acidity and Gastroesophageal Reflux in Patients with Gastroesophageal Reflux Disease

1998 • 32 citations

Therapeutic Options in Nonulcer Dyspepsia

2001 • 32 citations

Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers

2001 • 30 citations

Treatment of chronic hepatitis B virus infection: An Asia–Pacific perspective

1999 • 29 citations

Peptic ulcer disease and current approaches to Helicobacter pylori

2001 • 28 citations

Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori

1998 • 27 citations

Low‐dose lansoprazole provides greater relief of heartburn and epigastric pain than low‐dose omeprazole in patients with acid‐related dyspepsia

1999 • 27 citations

Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study

1998 • 26 citations

Acid‐inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori‐negative healthy subjects

1998 • 24 citations

Rapid Effect of Lansoprazole on Intragastric pH: a Crossover Comparison with Omeprazole

1999 • 23 citations

Review article: nonsteroidal anti-inflammatory drug-associated gastrointestinal complications—guidelines for prevention and treatment

1999 • 22 citations

Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro

1997 • 22 citations

Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline

2000 • 21 citations

Comparison between selective and nonselective nitric oxide synthase inhibition and phenylephrine in normal and endotoxic swine

2000 • 20 citations

Low-dose lansoprazole: Effective for non-ulcer dyspepsia (NUD)

2000 • 19 citations

Comparison of two 3‐day Helicobacter pylori eradication regimens with a standard 1‐week regimen

1999 • 18 citations

Lack of Pharmacokinetic Interaction between Lansoprazole and Intravenously Administered Phenytoin

1999 • 17 citations

Effect of 7-Day Therapy with Different Doses of the Proton Pump Inhibitor Lansoprazole on the Intragastric pH in Healthy Human Subjects

1999 • 17 citations

Role of Drug Therapy in the Treatment of Gastro-Oesophageal Reflux Disorder in Children

2000 • 14 citations

Pharmacological therapy of Helicobacter pylori infection.

1997 • 14 citations

Gene therapy experiments put on "clinical hold"

2000 • 13 citations

Pharmacokinetic Interaction Between Acetaminophen and Lansoprazole

1999 • 12 citations

Lansoprazole is superior to ranitidine as maintenance treatment for the prevention of duodenal ulcer relapse

1999 • 11 citations

In vitro activity of ebrotidine, ranitidine, omeprazole, lansoprazole, and bismuth citrate against clinical isolates ofHelicobacter pylori

1998 • 11 citations

Treatment of Helicobacter pylori

1999 • 10 citations

Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer.

1998 • 10 citations

Adolescent patients with gastroesophageal reflux disease (GERD): Results from a randomized trial of lansoprazole

2000 • 10 citations

Short-term treatment with amoxycillin, clarithromycin and lansoprazole during Helicobacter pylori infection in children

1999 • 10 citations

Safety review in 10,008 users of lansoprazole in daily practice

2000 • 9 citations

Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?

2000 • 9 citations

Prevention of duodenal ulcer recurrence with 15 mg lansoprazole: a double-blind placebo-controlled study. The Lansoprazole Study Group.

1997 • 9 citations

Lack of Interaction between Lansoprazole and Propranolol, a Pharmacokinetic and Safety Assessment

2000 • 9 citations

Double‐blind comparison of lansoprazole 15 mg, lansoprazole 30 mg and placebo as maintenance therapy in patients with healed duodenal ulcers resistant to H₂‐receptor antagonists

1999 • 8 citations

Lansoprazole pharmacokinetics differ in patients with oesophagitis compared to healthy volunteers

1999 • 8 citations

Lansoprazole reduces ulcer relapse after eradication of helicobacter pylori in NSAIDS users

2000 • 7 citations

Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method

1998 • 6 citations

First comparison pantoprazole versus lansoprazole in hospital and private practice patients with reflux esophagitis

1998 • 6 citations

Guidelines for Approaching Suspected Peptic Ulcer Disease or Helicobacter pylori Infection: Where We Are in Pediatrics, and How We Got There

2001 • 5 citations

From the Food and Drug Administration

1990 • 4 citations

Lansoprazole in the treatment of H. pylori infection in children

1998 • 4 citations

What is the preferred dose of lansoprazole in the maintenance therapy of reflux oesophagitis? The results of a Dutch multi-center comparative trial

1998 • 3 citations

Pharmacokinetics of lansoprazole in adolescent patients with gastroesophageal reflux disease (GERD)

2000 • 3 citations

Bactericidal activity of lansoprazole and omeprazole against Helicobacter pylori in vitro.

1998 • 2 citations

Effect of lansoprazole (L) on the steady-state pharmacokinetics of metronidazole (M) following concomitant administration of both drugs in 24 healthy volunteers

1998 • 2 citations

A prospective randomised controlled trial comparing daily, alternate day and PRN lansoprazole in the maintenance treatment of eosophagitis

1998 • 1 citations

One-week low-dose lansoprazole triple therapy for eradication of Helicobacter pylori: A large multicentre, randomised trial

2000 • 1 citations

The efficacy and safety of lansoprazole (LAN) 30mg once daily vs cisapride (CIS) 20 mg twice daily for 8 weeks in the acute treatment of erosive reflux oesophagitis (ERO)

2000 • 1 citations

Deleted Work

1955 • 0 citations